Profound Medical Corp.
PROF
$6.37
-$0.05-0.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.22M | 650.00K | 820.00K | 1.06M | 179.00K |
| Total Other Revenue | 4.07M | 1.56M | 1.80M | 2.65M | 2.65M |
| Total Revenue | 5.29M | 2.21M | 2.62M | 3.71M | 2.83M |
| Cost of Revenue | 1.36M | 593.00K | 768.00K | 1.18M | 1.04M |
| Gross Profit | 3.93M | 1.62M | 1.85M | 2.52M | 1.79M |
| SG&A Expenses | 7.43M | 9.33M | 8.21M | 6.60M | 6.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.20M | 16.02M | 13.79M | 12.46M | 11.83M |
| Operating Income | -8.91M | -13.81M | -11.17M | -8.76M | -9.00M |
| Income Before Tax | -7.86M | -15.63M | -10.68M | -5.57M | -9.19M |
| Income Tax Expenses | 121.00K | 64.00K | 41.00K | -238.00K | 177.00K |
| Earnings from Continuing Operations | -7.98M | -15.70M | -10.72M | -5.33M | -9.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.98M | -15.70M | -10.72M | -5.33M | -9.37M |
| EBIT | -8.91M | -13.81M | -11.17M | -8.76M | -9.00M |
| EBITDA | -8.77M | -13.67M | -11.00M | -8.39M | -8.78M |
| EPS Basic | -0.27 | -0.52 | -0.36 | -0.21 | -0.38 |
| Normalized Basic EPS | -0.16 | -0.33 | -0.22 | -0.14 | -0.23 |
| EPS Diluted | -0.27 | -0.52 | -0.36 | -0.21 | -0.38 |
| Normalized Diluted EPS | -0.16 | -0.33 | -0.22 | -0.14 | -0.23 |
| Average Basic Shares Outstanding | 30.10M | 30.05M | 30.04M | 25.77M | 24.54M |
| Average Diluted Shares Outstanding | 30.10M | 30.05M | 30.04M | 25.77M | 24.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |